TWD
AUPH icon

True Wealth Design’s Aurinia Pharmaceuticals AUPH Stock Holding History

True Wealth Design’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-356
Closed -$2.86K – 2588
2025
Q1 		$2.86K Buy
356
+274
+334% +$2.22K ﹤0.01% 882
2024
Q4 		$737 Sell
82
-386
-82% -$3.15K ﹤0.01% 1016
2024
Q3 		$3.43K Buy
+468
New +$2.9K ﹤0.01% 661

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

True Wealth Design's AUPH Position: Q2 2025 in Review

True Wealth Design sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 356 shares — an estimated $2.86K sold.

True Wealth Design first reported a position in AUPH in Q3 2024 and held it in 3 quarters. The position peaked at $3.43K in Q3 2024. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • True Wealth Design reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • True Wealth Design sold 356 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $2.86K.
  • True Wealth Design first reported a position in Aurinia Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • True Wealth Design's Aurinia Pharmaceuticals position peaked at $3.43K in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on True Wealth Design's 13F filing for Q2 2025, filed 6 Aug 2025.